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Abstract
Background: Neurocognitive dysfunction is a critical target symptom of schizophrenia treatment. A positive
correlation between physical activity level and neurocognitive function has been reported in healthy individuals,
but it is unclear whether such a correlation exists in patients with schizophrenia and whether the relationship is
different according to inpatients or outpatients. This study aimed to examine the differences in the correlations
between physical activity and multiple neurocognitive domains in inpatients and outpatients with schizophrenia
and obtain suggestions for further study to facilitate this field.
Methods: Twenty-nine patients with schizophrenia were examined (16 inpatients and 13 outpatients, 56.0 ± 11.4 years
of age). Current symptoms were assessed using the Positive and Negative Symptom Scale and neurocognitive
functions using Cognitrax, which yields a composite neurocognitive index (NCI) and 11 domain scores. After
testing, participants wore an HJA-750C accelerometer for one week to measure physical activity levels and
durations. Partial correlation analyses were performed between exercise and cognitive parameters.
Results: In the outpatient group, higher physical activity was associated with faster Motor and Psychomotor
Speeds in outpatients. However, higher physical activity was associated with lower overall NCI, Attention score,
and Memory scores in inpatients.
Conclusion: Although higher physical activity was associated with better neurocognitive functions of outpatients,
in inpatients with non-remitted schizophrenia, higher physical activity was associated with worsening of several
cognitive domains. In a future study examining the relationship between physical activity and neurocognitive
function for facilitating this research field, separation between inpatients and outpatients are needed because the
relationship is different between inpatients and outpatients.
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Background
In addition to prominent positive and negative symp-
toms, several patients with schizophrenia have neuro-
cognitive deficits. The severity of these deficits is a
strong predictor of poor social functioning [1] and
issues in daily life [2]; therefore, cognitive dysfunction
is recognised as a core feature of schizophrenia, and
comprehensive treatment must include improvement
or maintenance of cognitive functioning and mitigation
of positive and negative symptoms.
In healthy individuals, physical activity can improve
cognitive function. A large 26-year cohort study [3] re-
ported that healthy people who routinely exercised
showed better cognitive performance than sedentary
people. A meta-analysis by Hidin et al. [4] of studies
involving healthy adults ≥55 years concluded that phys-
ical activity improves cognitive function. In addition,
Smith et al. [5] conducted a systematic review of 29
randomised controlled trails (RCTs) and concluded
that aerobic activity enhances cognitive function in
healthy adults.
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On the other hand, the effects of physical activity on
neurocognitive functions in clinical populations are yet
unclear. A recent review [6, 7] stated that such studies
have neglected the effects of physical exercise on cogni-
tive performance in patients with schizophrenia despite
the strong association between cognitive function and
clinical outcome. Pajonk et al. [8] conducted an RCT in-
cluding 24 schizophrenia outpatients and reported im-
proved memory and large hippocampal volume in active
patients compared with the non-exercising patient
group. Kimhy et al. [9] reported that maximum oxygen
consumption, one indicator of physical activity level, was
positively correlated with cognitive function in 32
schizophrenia outpatients. Similarly, Leutwyler et al. [10]
reported a positive correlation between physical activity
level and Processing Speed in schizophrenia outpatients.
However, several issues are yet unclear. First, the cor-
relation between cognitive function and physical activity
has not been investigated in inpatients with schizophre-
nia. If inpatients were included in a study, only the
combing score of inpatients and outpatients was ana-
lysed. No subgroup analysis of inpatients and outpatients
was performed. Because several factors influence cogni-
tive function differently based on whether the disease is
well controlled or active (in outpatients and inpatients,
respectively) [11], the effects of physical activity may dif-
fer. To facilitate the study field, subgroup analysis of in-
patients and outpatients is needed. Second, most studies
have reported only one or a few measures; however, cog-
nitive function consists of multiple elements or neuro-
cognitive domains. The MATRICS Consensus Cognitive
Battery includes 7 domains that are considered necessary
for a complete evaluation of cognitive functioning in
schizophrenia [12]. However, most previous studies have
only investigated the correlation between physical activ-
ity and memory or general cognitive function [13].
Clarifying the correlations between physical activity
and the neurocognitive domains affected in schizophre-
nia could facilitate decisions regarding treatment and
hospital discharge, which would relieve the burden on
institutions with limited capacity. This preliminary study
aimed to examine the correlations between physical ac-
tivity levels and multiple neurocognitive domains as
measured using the Cognitrax testing system in patients
with schizophrenia. It also aimed to examine differences
in these correlations according to the treatment site (in-
patient vs. outpatient) and to obtain suggestions for fur-
ther study to facilitate this field.
Methods
Study design
This was a cross-sectional study including 29 patients
diagnosed with schizophrenia (enrolled from two centres
in Osaka, Japan).
Participants
All participants were recruited from closed psychi-
atric hospital wards or day care centres. Inclusion
criteria were as follows: (1) diagnosis of schizophre-
nia by their doctors, (2) consent from both the pa-
tient and treating physician, (3) voluntary treatment
at a day care centre for outpatients and (4) voluntary
hospitalization according to Japanese law for inpa-
tients. To enhance the comparability between inpa-
tients and outpatients, we included inpatients under
voluntary hospitalization. For example, there may be
the bias that the data of inpatients under non-
voluntary hospitalization tended to have more differ-
ences with the data of outpatients compared with the
data of inpatients under voluntary hospitalization.
Exclusion criteria were as follows: (1) severe psychi-
atric symptoms such as those requiring seclusion or
body restraint, (2) no dependent gait, (3) <20 years
old, (4) treated using lobotomy.
Measurements
Demographics
Demographic and baseline clinical information (age, sex,
age of onset, duration of illness, length of stay, body
mass index (BMI), blood pressure, education, and the
category and dose of medications) was collected from
medical records. The dose of antipsychotics was calcu-
lated by chlorpromazine (CP) equivalents, antianxiety
medication by diazepam equivalents, and anti-Parkinsonian
medication by biperiden equivalents.
Psychiatric symptoms
The Positive and Negative Syndrome Scale (PANSS),
consisting of positive, negative, and general psycho-
pathology scales, was used to assess current psychiatric
symptoms. The validity and reliability of PANSS has
been demonstrated [14]. All 30 items were rated on a
scale from 1 (absent) to 7 (severe) based on symptom
severity over a week. The 3 subscale scores and total
score on PANSS were used in analysis.
Remission was defined according to Andreasen et al.
[15] as scores of ≤3 for delusions (P1), conceptual
disorganization (P2) hallucinatory behaviour (P3),
blunted affect (N1), passive apathetic social withdrawal
(N4), lack of spontaneity and flow of conversation
(N6), mannerisms and posturing (G5) and unusual
thought content (G9).
We evaluated all psychiatric symptom scores on PANSS
according to instructions from trained psychiatrists.
Neurocognitive functions
The Cognitrax basic package has been extensively evalu-
ated for reliability and validity [16] and was used to
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examine neurocognitive functions. The participants per-
formed seven tasks displayed on a personal computer:
Verbal Memory, Visual Memory, Finger Tapping,
Symbol Digit Cording, Stroop Test, Shifting Attention
and Continuous Performance Test. Based on the scores
on the 7 tasks, a composite Neurocognition Index (NCI)
and 11 Domain Scores were calculated (Composite
Memory, Verbal Memory, Visual Memory, Psychomotor
Speed, Reaction Time, Complex Attention, Cognitive
Flexibility, Processing Speed, Executive Function, Simple
Attention and Motor Speed). Individual scores were
standardised by setting the mean score to 100 and the
standard deviation (SD) to 15; therefore, the scores in
participants can be compared those in healthy people
without investigating healthy people [16]. Higher score
indicates better neurocognitive function.
Physical activity
The participants wore a triaxial accelerometer (Active
style pro HJA-750C; Omron Colin Co., Ltd., Kyoto,
Japan) at the waist for 1 week to measure physical activity.
HJA-750C can record METs (metabolic equivalents),
EX (Exercise: >3 MET ×minutes), total steps per day,
total time for step, total calorie consumption, and the
daily minutes of physical activity categorized as seden-
tary (<3.0 METs), moderate (3–5.9METs), and vigorous
(≥6.0 METs). All activity indicators used for analysis
were calculated as average per day for more than week.
These indicators were previously validated [17].
We instructed participants to wear HJA-750C from
waking until they slept, for more than 6 h per day,
except during showers and baths. To do this, a leaflet
which demonstrated adequate wearing was used. To en-
sure adequate measurement of physical activity, ward
nurses instructed the participants on proper wearing of
the HJA-750C.
Procedures
All data were collected from Sep 2015 to Mar 2016.
Interviews for measuring psychiatric symptoms and
neurocognitive functions were conducted in a private
meeting room on the ward. First, we conducted the
interview to measure psychiatric symptoms. Next, neu-
rocognitive functions were examined via PC. Finally,
immediately after measuring neurocognitive functions,
we requested the participants to wear the HJA-750C
for 1 week. All psychometric tests were conducted on
one day per participant.
Statistical analysis
The participants were divided into 2 groups: the inpa-
tients group and the outpatients group. The following
statistical analyses were performed separately with the
inpatients and outpatients groups. First, in all statistical
analysis, parametric tests were chosen because nonpara-
metric analysis induces type II errors. The parameters
measured in this study were considered to have normal
distributions in other studies [16, 18], and recently,
parametric analyses have been used except for data with
extreme deviations from normal distributions [19].
Furthermore, the correlation of the absolute value was
important to the aim of this study, not of rank order in
these participants. Therefore, parametric analyses were
introduced in this study.
Pearson coefficients were calculated to determine the
correlations of demographic variables and psychiatric
symptoms with neurocognitive functions (NCI and the
11 domain scores). Second, partial correlation analyses
were performed to determine the statistical associations
between physical activity and neurocognitive functions
(NCI and the 11 domain scores), with controlling for
confounder variables that correlated with neurocogni-
tive functions (e.g., age). The partial correlation in the
inpatient group was compared with that in the out-
patient group.
Using IBM SPSS Sample Power version 3, we esti-
mated that 26 participants were required for a power of
0.8 at alpha = 0.05 assuming a correlation coefficient of
0.5 [10]. Values of p < 0.05 were considered significant.
All statistical analyses were performed using SPSS for
Windows version 23.0.
Ethical consideration
Participants and their doctors were informed of the
study aims and methods using a leaflet. Patients were
free to participate or refuse without consequences. All
participants and their doctors provided written consent
to the study. We asked their doctors to estimate whether
participation of patients might affect the state of the
patients or not. Then, if the doctor thought that there
would be no effect, they gave written consent for the pa-
tient in the study. Because individuals who were younger
than 20 years old are considered to be minors according
to the Japanese law, for grantee voluntary participate,
they were exclusive. The research protocol was approved
by the ethics committee of Kansai University of Health
Science before beginning the investigation.
Results
All measurements of all participants (16 inpatients and
13 outpatients) were investigated in this study. Demo-
graphic features, mean psychometric scores and accel-
erometry values are shown in Table 1. None of the
inpatients were in remission according to the criteria
of Andreasen et al. [15], whereas 3 outpatients were in
remission.
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Correlational analyses in inpatients
In inpatients, the raw correlational analyses among
demographics, psychiatric symptoms, and neurocognitive
functions are shown in the Additional file 1: Table S1.
The partial correlation analyses revealed that the total
NCI, Complex Attention domain score, and Simple
Attention domain score were negatively correlated with
physical activity (Table 2). Furthermore, Composite
Memory, Verbal Memory, and Visual Memory domain
scores were negatively correlated with the time spent in
vigorous exercise (>6 METs).
Correlational analysis in outpatients
In outpatients, the raw correlational analyses among
demographics, psychiatric symptoms, and neurocognitive
functions are shown in the Additional file 1: Table S2. The
partial correlation analyses revealed that the Psychomotor
Speed and Motor Speed domains were positively corre-
lated with physical activity (Table 3).
Discussion
This pilot study examining the correlations between
physical activity levels and multiple neurocognitive do-
mains revealed that the pattern of correlation differed
according to neurocognitive function and treatment site.
In outpatients, higher physical activity was associated
with faster Psychomotor and Motor Speeds but not
with Attentional and Memory domain scores. In inpa-
tients, higher physical activity was associated with
lower Neurocognitive Index, Complex Attention
domain score, Simple Attention domain score, and
Memory domain scores.
Leutwyler et al. [10] reported a positive correlation
between motor speed and total calorie consumption but
no correlations with other neurocognitive domains in 30
patients with schizophrenia. Although a positive rela-
tionship between physical activity and motor speed is
consistent with our results in outpatients (Table 3), we
found a strong negative correlation between physical
activity and attentional function in inpatients, but not in
outpatients (Tables 2 and 3). Thus, physical activity ap-
pears to have distinct relationships with different neuro-
cognitive domains. Furthermore, the correlation pattern
between physical activity and neurocognitive domains
differed between inpatients and outpatients. These au-
thors [10] observed a positive correlation between daily
minutes of moderate physical activity and Processing
Speed, although we found no significant association.
Moreover, Kimhy et al. [9] reported a positive association
between maximum oxygen consumption and neurocogni-
tive function in schizophrenia outpatients. Kimhy et al.
[20] and Ho et al. [21] has conducted an RCT of exercise
in outpatients with schizophrenia and reported that
the aerobic group showed greater improvements in







Age 59.4 ± 12.1 51.8 ± 9.3
Age of onset 27.9 ± 13.5 29.2 ± 9.2
Duration of illness (year) 31.6 ± 14.2 22.6 ± 9.8
Length of stay (month) 207.0 ± 175.9 22.4 ± 46.3
BMI 23.2 ± 2.6 25.1 ± 5.6
Dosage of FGA ( mg ) 240.8 ± 334.4 49.0 ± 110.2
Dosage of SGA ( mg ) 944.2 ± 700.0 851.6 ± 504.9
Sum dosage of antipsychotics ( mg ) 1185.0 ± 890.4 900.6 ± 585.5
Biperiden ( mg ) 3.1 ± 3.9 1.3 ± 1.5
Diazepam ( mg ) 15.5 ± 14.0 14.0 ± 11.9
Psychiatric symptoms
Positive scale 14.1 ± 4.9 11.5 ± 3.7
Negative scale 25.7 ± 5.8 16.2 ± 5.6
General psychopathology scale 33.9 ± 6.5 24.2 ± 4.0
PANSS 73.6 ± 13.3 51.9 ± 8.5
Neurocognitive function
Neurocognitive Index 56.1 ± 21.6 71.0 ± 17.3
Composite Memory 58.7 ± 26.7 67.8 ± 29.1
Verbal Memory 64.6 ± 26.7 74.4 ± 23.4
Visual Memory 68.4 ± 20.2 85.6 ± 20.4
Psychomotor Speed 65.8 ± 17.2 80.8 ± 18.6
Reaction Time 69.8 ± 36.1 59.4 ± 17.0
Complex Attention 34.0 ± 56.6 75.2 ± 25.6
Cognitivie Flexibility 49.8 ± 21.5 64.6 ± 21.6
Processing Speed 71.4 ± 19.2 84.8 ± 15.3
Executive Function 51.4 ± 18.2 65.1 ± 20.8
Simple Attention −6.9 ± 167.2 93.7 ± 26.0
Motor Speed 72.7 ± 18.3 84.8 ± 18.7
Physical activity
Calory consumption of walking (kcal) 157.3 ± 181.2 218.4 ± 239.3
Calory consumption of daily activity (kcal) 288.5 ± 129.0 314.5 ± 161.5
Calory consumption of activity (kcal) 445.8 ± 288.1 533.0 ± 314.9
Total calory consumption (kcal) 2013.3 ± 417.8 2064.1 ± 527.3
Ex of walking 2.0 ± 3.0 3.2 ± 3.8
Ex of daily activity 1.2 ± 0.8 1.9 ± 1.3
Total Ex 3.1 ± 3.6 5.1 ± 4.1
Steps 5398.1 ± 6011.7 6821.6 ± 6667.9
Times of walking (min / a day) 69.3 ± 62.7 87.8 ± 71.4
Spending time of sedentary
(1 ~ 2.9METS)
662.7 ± 248.4 499.3 ± 189.7
Spending time of moderate
(3 ~ 5.9METS)
47.0 ± 59.6 76.4 ± 56.2
Spending time of vigorous
(6 ~ 8.9METS)
2.8 ± 8.3 1.6 ± 2.7
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neurocognitive functions than the control (treatment
as usual) group. Thus, physical activity appears to dif-
ferentially relate to the neurocognitive functioning of
inpatients and outpatients, with clear benefits in out-
patients but not in inpatients.
In contrast to our results, Oertal et al. [22] reported
beneficial effects of aerobic exercise on neurocognitive
function in inpatients with acute phase schizophrenia.
However, the discrepancy with our results may stem
from the difference in symptom severity, as the PANSS
negative symptom score in the study of Oertal et al. [22]
was only 15.55 ± 30.1, markedly lower than in our study
(25.7 ± 5.8). This suggests that the relationships between
better neurocognitive function and higher physical activity
may not emerge in inpatients with schizophrenia, indi-
cating severe negative symptoms. The participants in
the current study were non-remitted and generally
more severely affected by schizophrenic symptoms. The
mean antipsychotic dose in the study by Kimhy et al.
[9] was 351.38 ± 291.77 mg, markedly lower than that
of our inpatient group (1185.0 ± 890.4 mg). Moreover,
the participants in the current study were older (59.4 ±
12.1 years old). Thus, the participants in this study are
likely more to be more treatment resistant. We suggest
that the features of treatment-resistance may influence
the relationships between physical activity and several
neurocognitive domains.
These negative correlations with high physical activity
level may be explained by the following two points: the
particularly strong negative correlations with Complex
Attention and Simple Attention domains in inpatients
and the basal nucleus.
Attentional functions are the foundations for other
neurocognitive domains. Briefly, if attentional function
deteriorates, tests for other neurocognitive domains
cannot be performed to the participants’ full ability.
This may account for the observed reductions in NCI
and domain scores for Composite Memory, Verbal
Memory, and Visual Memory with longer time spent in
vigorous exercise.
In contrast, the basal nucleus is associated not only
with moving but also with attention and learning [23].
Abnormality of the basal nucleus in schizophrenia has
been reported [24]. Furthermore, anatomical differences
in the basal nucleus between treatment-responsive and
treatment-resistant patients have been reported in a re-
cent systematic review [25]. Therefore, when patients
with treatment-resistant schizophrenia do hard physical
activity, it is thought that disability related to treatment
resistance decreases the ability to deal with attention
and learning, via basal nucleus hyperactivity. However,
given the cross-sectional study design, the relationship
can also be explained by oppositional interpretation; in-
patients with worse attentional deficits tend to bustle.
Because there is no evidence that can conclude the
mechanism underlying the relationships, we can conclude
the causal relationships between high physical activity and
worse attentional function.
Therefore, a future study is needed to examine the re-
lationship between physical activity and neurocognitive
function, separating inpatients from outpatients, and fur-
thermore to reveal difference in effects of physical activity
on brain activity using interventional study design.
This study’s design has several limitations. First, the sam-
ple size was small, and convenience sampling was used;
therefore, the results will not be generalizable. In compari-
son with a large-scale study in Japan, the average age of
this sample (59.4 ± 12.1 years) was relatively older than
that of the large scale study (51.9 ± 11.6 years) [8, 21, 26].
Advanced age may affect the relationship between physical
activity and neurocognitive function. Thus, future studies
are warranted to investigate a larger sample of patients,
using probability sampling, to ensure generalizability.
Second, parametric analysis was performed in this study
to examine the relationships between physical activity and
neurocognitive function after controlling for other con-
founding factors (demographics and psychiatric symp-
toms), although the sample size was limited. Third, the
study was cross-sectional; therefore, no causal correlation
could be established. Fourth, as these patients become
more treatment resistant, future studies are required to
determine the influence of physical activity levels on neu-
rocognitive function in treatment-responsive inpatients.
Third, the clinical significance of the relationship between
physical activity and neurocognitive function could not be
determined in this study.
However, the strength of this study was that the differ-
ences in the relationships between physical activity and
neurocognitive function among inpatients and outpatients
were examined, controlling for several confounding fac-
tors, which commonly affect data, such as demographics
and psychiatric symptoms, in a clinical setting. Further
studies are needed controlling for other confounding
factors to investigate the differences between in-patients
and out-patients.
Conclusion
The correlation between physical activity and neurocogni-
tive function were different, according to neurocognitive
domains and treatment sites. In separated analysis accord-
ing to the treatment sites (inpatients and outpatients),
physical activity has only a negative correlation with neu-
rocognitive function in inpatients, although it had only a
positive correlation with neurocognitive function in out-
patients. Therefore, when correlations between physical
activity and neurocognitive function are examined, the
analysis should be performed, separating inpatients par-
ticularly treatment-resistance patients from outpatients.
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Additional file
Additional file 1: Table S1. The correlation among Demographics,
Psychiatric symptoms, and Neurocognitive functions in inpatients group
(n = 16). Table S2. The correlation among Demographics, Psychiatric
symptoms, and Neurocognitive functions in outpatients group (n = 13).
(XLSX 26 kb)
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